Search alternatives:
largest decrease » largest decreases (Expand Search), marked decrease (Expand Search)
larger decrease » marked decrease (Expand Search)
peer decrease » teer decrease (Expand Search), step decrease (Expand Search), we decrease (Expand Search)
mean decrease » a decrease (Expand Search)
largest decrease » largest decreases (Expand Search), marked decrease (Expand Search)
larger decrease » marked decrease (Expand Search)
peer decrease » teer decrease (Expand Search), step decrease (Expand Search), we decrease (Expand Search)
mean decrease » a decrease (Expand Search)
-
6341
-
6342
-
6343
-
6344
The NK1-receptor antagonist ezlopitant significantly decreases the breakpoint for sucrose but not ethanol operant self-administration in rats.
Published 2013“…<p>Ezlopitant (5 and 10 mg/kg i.p.) decreases the breakpoint for 5% sucrose using a PR schedule (<b>A</b>), but had no effect on the breakpoint for 10% ethanol (<b>B</b>). …”
-
6345
Spatial stability is decreased in APP/PS1 mice in both dCA1 and vCA1.
Published 2024“…<p>(A) In dCA1, stability score was significantly decreased in APP/PS1 mice relative to C57BL/6 mice (mean ± std: C57BL/6 = -0.009 ± 0.292, APP/PS1 = -0.1845 ± 0.256, p < 10<sup>−6</sup>, two-sided Wilcoxon rank-sum test, n<sub>C57BL/6</sub> = 295 units from 5 recording sessions, n<sub>APP/PS1</sub> = 167 units from 4 recording sessions). …”
-
6346
-
6347
-
6348
-
6349
-
6350
-
6351
-
6352
-
6353
-
6354
-
6355
Divergent effects of DYRK1A KD in HBV-infected PHH.
Published 2024“…(B) Representative Western blot analysis of DYRK1A KD levels. (C) and (D) DYRK1A and HBV RNA analysis of a set of 3 independent experiments, each performed in triplicate, in which a decrease of HBV RNAs was observed. …”
-
6356
-
6357
-
6358
-
6359
-
6360